Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,867 | 1,376 | 98.3% |
| Education | $348.34 | 16 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,865 | 102 | $0 (2024) |
| PFIZER INC. | $1,762 | 130 | $0 (2024) |
| ABBVIE INC. | $1,582 | 117 | $0 (2024) |
| Novo Nordisk Inc | $1,562 | 123 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,231 | 98 | $0 (2024) |
| Daiichi Sankyo Inc. | $1,193 | 77 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,084 | 79 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,080 | 77 | $0 (2024) |
| Lilly USA, LLC | $1,078 | 79 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $841.55 | 57 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,077 | 127 | PFIZER INC. ($308.67) |
| 2023 | $2,662 | 153 | AbbVie Inc. ($350.41) |
| 2022 | $2,687 | 178 | ABBVIE INC. ($328.37) |
| 2021 | $2,749 | 200 | AbbVie Inc. ($443.65) |
| 2020 | $2,695 | 184 | Novo Nordisk Inc ($336.79) |
| 2019 | $2,520 | 186 | AstraZeneca Pharmaceuticals LP ($324.19) |
| 2018 | $2,652 | 190 | PFIZER INC. ($307.49) |
| 2017 | $2,174 | 174 | AstraZeneca Pharmaceuticals LP ($306.50) |
All Payment Transactions
1,392 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: PAIN | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: PAIN | ||||||
| 12/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Bone Health | ||||||
| 12/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Oncology | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: PAIN | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.77 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: VACCINES | ||||||
| 10/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,007 | 4,848 | $272,421 | $145,526 |
| 2022 | 23 | 2,172 | 5,145 | $293,361 | $155,811 |
| 2021 | 22 | 2,393 | 5,768 | $331,592 | $176,994 |
| 2020 | 27 | 2,882 | 6,132 | $392,285 | $197,344 |
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 298 | 589 | $86,640 | $46,640 | 53.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 437 | $41,515 | $26,002 | 62.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 205 | 205 | $51,250 | $25,014 | 48.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 64 | $17,060 | $8,380 | 49.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 337 | 967 | $5,802 | $5,681 | 97.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 25 | 27 | $7,560 | $5,607 | 74.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 25 | $5,000 | $3,831 | 76.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 59 | $5,900 | $3,699 | 62.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 43 | 60 | $5,720 | $3,698 | 64.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 198 | 198 | $3,960 | $3,388 | 85.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 100 | 100 | $5,000 | $3,172 | 63.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 100 | 100 | $3,500 | $2,850 | 81.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 101 | 257 | $7,710 | $2,442 | 31.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 37 | 48 | $3,227 | $1,837 | 56.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 16 | 27 | $1,487 | $706.33 | 47.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 77 | 80 | $4,240 | $685.31 | 16.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 28 | 30 | $1,800 | $568.40 | 31.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 23 | 40 | $600.00 | $561.60 | 93.6% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 12 | 12 | $420.00 | $296.04 | 70.5% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 51 | 51 | $306.00 | $218.79 | 71.5% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 63 | 320 | $5,120 | $130.22 | 2.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 95 | 1,080 | $7,020 | $93.02 | 1.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 32 | 72 | $1,584 | $24.54 | 1.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 337 | 653 | $92,520 | $51,328 | 55.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 70 | 553 | $52,535 | $30,324 | 57.7% |
About Dr. Stephen Browne, M.D
Dr. Stephen Browne, M.D is a Internal Medicine healthcare provider based in Northport, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306808845.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Browne, M.D has received a total of $20,215 in payments from pharmaceutical and medical device companies, with $2,077 received in 2024. These payments were reported across 1,392 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($19,867).
As a Medicare-enrolled provider, Browne has provided services to 9,454 Medicare beneficiaries, totaling 21,893 services with total Medicare billing of $675,675. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Northport, AL
- Active Since 04/03/2006
- Last Updated 02/01/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1306808845
Products in Payments
- FARXIGA (Drug) $1,253
- TRELEGY ELLIPTA (Drug) $1,053
- ELIQUIS (Drug) $1,053
- INJECTAFER (Drug) $995.80
- XARELTO (Drug) $981.82
- VRAYLAR (Drug) $876.40
- Ozempic (Drug) $830.28
- ENTRESTO (Drug) $723.02
- JARDIANCE (Drug) $647.03
- Vascepa (Drug) $616.04
- UBRELVY (Drug) $447.90
- MOUNJARO (Drug) $440.59
- Kerendia (Drug) $386.13
- TRINTELLIX (Drug) $373.14
- TRULICITY (Drug) $363.98
- JANUVIA (Drug) $310.43
- SYMBICORT (Drug) $308.02
- LYRICA (Drug) $304.34
- CAPLYTA (Drug) $275.27
- Victoza (Drug) $263.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Northport
Brittany Hill, Do, DO
Internal Medicine — Payments: $16,519
Paul Leva, Md, MD
Internal Medicine — Payments: $14,754
Ginny Leva, Md, MD
Internal Medicine — Payments: $8,840
Mr. Roger Perrone, M.d, M.D
Internal Medicine — Payments: $1,748
Dr. Richard Boughal, Md, MD
Internal Medicine — Payments: $756.92
Dr. Hillary Diamond, M.d, M.D
Internal Medicine — Payments: $601.48